MX9701302A - Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos. - Google Patents

Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.

Info

Publication number
MX9701302A
MX9701302A MX9701302A MX9701302A MX9701302A MX 9701302 A MX9701302 A MX 9701302A MX 9701302 A MX9701302 A MX 9701302A MX 9701302 A MX9701302 A MX 9701302A MX 9701302 A MX9701302 A MX 9701302A
Authority
MX
Mexico
Prior art keywords
oestradiol
transdermal therapeutic
therapeutic system
active substance
matrix
Prior art date
Application number
MX9701302A
Other languages
English (en)
Inventor
Walter Muller
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MX9701302A publication Critical patent/MX9701302A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

La invencion se refiere a un sistema transdérmico que contiene estradiol como substancia activa y tiene una estructura colocada por capas. Esta estructura colocada por capas comprende un refuerzo que es impermeable a la substancia activa y a la humedad, una matriz que contiene substancia activa y, posiblemente, una capa protectora separable que cubre la matriz. El sistema está caracterizado en que la matriz contiene glicerol el cual contiene un máximo de 1% de agua o que es substancialmente anhidro.
MX9701302A 1994-08-20 1995-08-12 Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos. MX9701302A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429667A DE4429667C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003201 WO1996005814A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (1)

Publication Number Publication Date
MX9701302A true MX9701302A (es) 1998-05-31

Family

ID=6526231

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701302A MX9701302A (es) 1994-08-20 1995-08-12 Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.

Country Status (22)

Country Link
US (1) US5902602A (es)
EP (1) EP0776199B1 (es)
JP (1) JP3825799B2 (es)
KR (1) KR100401136B1 (es)
CN (1) CN1078461C (es)
AT (1) ATE185067T1 (es)
AU (1) AU695970B2 (es)
CZ (1) CZ289397B6 (es)
DE (2) DE4429667C2 (es)
DK (1) DK0776199T3 (es)
ES (1) ES2139932T3 (es)
FI (1) FI118720B (es)
GR (1) GR3032218T3 (es)
HU (1) HU226959B1 (es)
IL (1) IL114949A (es)
MX (1) MX9701302A (es)
NO (1) NO313984B1 (es)
NZ (1) NZ291813A (es)
PL (1) PL180965B1 (es)
SK (1) SK281626B6 (es)
WO (1) WO1996005814A1 (es)
ZA (1) ZA956925B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
US11844753B2 (en) 2021-11-08 2023-12-19 Weiyong Li Transdermal drug delivery system for delivering a drug to a patient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
DD279818A1 (de) * 1989-02-06 1990-06-20 Jenapharm Veb Verfahren zur herstellung eines medizinischen pflasters
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
KR950701508A (ko) * 1992-06-11 1995-04-28 챨스 디 에버트 경피식 약물수송을 조절하기 위한 글리세린의 용도(the use of glycerin in moderating transdermal drug delivery)
AU678237B2 (en) * 1993-04-20 1997-05-22 Hexal Pharma Gmbh Active substance-containing plaster

Also Published As

Publication number Publication date
ATE185067T1 (de) 1999-10-15
GR3032218T3 (en) 2000-04-27
EP0776199B1 (de) 1999-09-29
DE59506962D1 (de) 1999-11-04
CZ289397B6 (cs) 2002-01-16
DE4429667C2 (de) 1996-07-11
NO313984B1 (no) 2003-01-13
DK0776199T3 (da) 2000-04-10
ES2139932T3 (es) 2000-02-16
AU695970B2 (en) 1998-08-27
WO1996005814A1 (de) 1996-02-29
NO970360D0 (no) 1997-01-28
PL180965B1 (pl) 2001-05-31
NZ291813A (en) 1998-01-26
US5902602A (en) 1999-05-11
EP0776199A1 (de) 1997-06-04
IL114949A0 (en) 1995-12-08
FI118720B (fi) 2008-02-29
KR970705381A (ko) 1997-10-09
ZA956925B (en) 1996-03-25
FI970701A0 (fi) 1997-02-19
HU226959B1 (en) 2010-03-29
JPH10504313A (ja) 1998-04-28
IL114949A (en) 1998-12-27
SK22097A3 (en) 1997-07-09
PL319013A1 (en) 1997-07-21
KR100401136B1 (ko) 2004-03-31
DE4429667A1 (de) 1996-02-22
NO970360L (no) 1997-01-28
AU3344995A (en) 1996-03-14
JP3825799B2 (ja) 2006-09-27
FI970701A (fi) 1997-02-19
CN1155835A (zh) 1997-07-30
SK281626B6 (sk) 2001-05-10
HUT77085A (hu) 1998-03-02
CZ50997A3 (en) 1997-06-11
CN1078461C (zh) 2002-01-30

Similar Documents

Publication Publication Date Title
DE59808922D1 (en) Transdermales therapeutisches system
KR860004638A (ko) 침투성 피부약제 패치(patch) 및 그 제조방법
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
EP0384266A3 (en) Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
MX9701302A (es) Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.
IL92924A0 (en) Superficial therapeutic system comprising an antineoplastic active substance
ZA956926B (en) Estradiol-TTS having water-binding additives
DK0776198T3 (da) Transdermalt, terapeutisk system med beskyttelse mod hydrolyse
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis